Skip to main content

Table 1 Recommendations summary for the Psychosocial care of individuals living with EB

From: Psychosocial recommendations for the care of children and adults with epidermolysis bullosa and their family: evidence based guidelines

Recommendations

Population

Grade strength

Quality of evidence (Average)

Quality of evidence

Key references

i. We strongly recommend easy access to psychosocial support to improve Quality of life (QoL)

A multidisciplinary approach in treating EB improves QoL for individuals with EB

 • Psychological support and close monitoring of EB improves QoL.

 • They facilitate participation in social activities.

 • Patients with all types of EB including EBS report a great impairment in QoL due to restrictions in physical and social activities.

Adults, children (n = 12/185) EBS; JEB; DDEB; RDEB; KS

Unclear if adults, children or both (n = 43/134) EBS; JEB; DDEB; RDEB;

Adults, children (n = 120/248) EBS; JEB; DDEB; RDEB

Review of inherited & autoimmune blistering diseases

B

2++

1-

2+

2+

2-

1-

[29]

[30]

[31]

[28]

[32]

ii. We strongly recommend psychosocial support to improve well-being

To promote self-efficacy and support around body image to aid psychological well-being

 • Having access to knowledge and resources about EB can help people have a greater role in managing their EB. This self-management can help improve well-being.

 • Improved self-efficacy and locus of control, as well as support around body-image could help to develop a more positive sense of well-being.

For support during transition periods in life (school transitions, transition into adulthood)

 • Communication and education about EB to improve people’s understanding.

 • Support from families, EB healthcare professionals and DEBRA.

Review of inherited &autoimmune blistering diseases

Adults (n = 87) RDEB, DEB, EBS

Children 10–14 years old (n = 11) EBS (autosomal recessive)

Young male adults (aged 21–35 years) with RDEB (n = 5) and EBS (n = 2)

Observational report

C

2+

1-

2+

2+

4

4

[32]

[33]

[34]

[35]

[36]

iii. We strongly recommend gaining access to psychosocial support for the whole family

People diagnosed with EB should be referred for psychosocial support as early as possible in childhood or in adulthood, if the person with EB wishes

• To support the family unit.

Encourage supportive network for the family, for example:

 • Education about EB for others

 • Provide access to DEBRA (or other EB support groups)

Children (n = 11/82) EBS; JEB; DDEB; RDEB

Children (n = 16) JEB Adult (n = 1) RDEB

C

2-

2-

2-

4

[37]

[38]

[39]α

iv. We recommend psychosocial support to help with pain

Pain is present for most children and adults with EB (all types) with profound psychosocial impact:

 • Activity related pain can significantly affect psychosocial well-being and QoL (e.g. fear of/actual pain restricting social activities, affecting relationships with family and friends).

 • Treatment related pain can make managing EB harder and link to procedural anxiety.

Adequate holistic pain management is essential as a focus for helping people with EB:

 • Following pain guidelines.

 • Offering approaches to help people with EB cope emotionally.

 • Help with managing the impact of pain and the interlinked cycle of pain and psychosocial challenges.

Adults, children(n = 374) EBS, JEB, DDEB, RDEB

Adults (n = 6) JEB, DDEB

Children; (n = 11) EBS, JEB, DDEB, RDEB,

Adults (n = 30) children (n = 27) EBS

Children/families (n = 70) type of EB unclear

Adults (n = 43) EBS, JEB, DDED, RDEB

Unclear if adult/child (n = 40)

EBS, JEB, DDEB, RDEB

Best practice guideline

Children (n = 11) EBS, JEB, DDEB, RDEB

Adult (n = 1) RDEB

C

2-

2+

2-

2-

2-

2-

2+

2+

2+

3

[3]

[40]

[37]

[42]

[41]

[30]

[44]

[7]α

[17]

[43]

v. We strongly recommend psychosocial support to help cope with living with EB

People with EB need support to cope with EB, and their ways of coping need to be supported by others: participation in social life needs to be supported

 • Such as at school, the community, friendships, employment.

 • Aid access to supportive networks.

 • Public education campaigns to help those around them to understand EB and their needs.

Promote a sense of self-management of their EB

 • This can help bring a sense of control over certain aspects of the disease/treatment and pain.

Build social skills and communication

 • Help in learning how to communicate about EB to others and within the family unit.

Children (n = 27) DDEB; (n = 28) RDEB

Children 10–14 years old (n = 11) EBS (autosomal recessive)

Children (n = 11/82)

EBS; JEB; DDEB; RDEB

Children (n = 24)

EBS; JEB; DDEB; RDEB

C

2-

2+

2+

2-

2-

[45]

[34]

[37]

[46]

vi. We strongly recommend psychosocial support from a multidisciplinary Health Care Team

Encourage access to, and a collaborative ‘working together’ relationship with, an expert multi-disciplinary team of professionals.

 • Facilitate access to multidisciplinary professional support for medical and psychosocial care across the lifespan.

 • At both specialist centres and community services

Adults, children (n = 15) RDEB

Children (n = 21) EBS; JEB; DDEB; RDEB

Children (n = 11/82) EBS; JEB; DDEB; RDEB

HCPs (n = 33) 30 stakeholders (HCPs, and 9 with EB RDEB, DDEB, EBS)

Adults (n = 6) JEB, DDEB

Children and Adults (n = 20) EBS, JEB, DEB

Children (n = 16) JEB

Children (n = 20) EBS, JEB, RDEB

C

2-

1-

2+

2+

2+

2-

2-

2-

2-

2-

2+

[29]

[48]

[51]

[17]

[46]

[49]

[40]

[38]

[48]

[47]

Key: EB: Epidermolysis Bullosa; RDEB: Recessive Dystrophic Epidermolysis Bullosa; JEB: Junctional Epidermolysis Bullosa; DDEB: Dominant Dystrophic Epidermolysis Bullosa; EBS: Epidermolysis Bullosa Simplex EBS-I: Localised form of EBS; KS Kindler Syndrome; QoL: quality of life; n: number of; α: gray literature; this is an EB guideline

Grades

Descriptions in accordance to SIGN [22]

 B

A body of evidence including studies rated as 2++, directly applicable to the target population, and demonstrating overall consistency of results; or Extrapolated evidence from studies rated as 1++ or 1+

 C

A body of evidence including studies rated as 2+, directly applicable to the target population and demonstrating overall consistency of results; or Extrapolated evidence from studies rated as 2++

Ratings Descriptions in accordance to SIGN [22]

 1-

Meta-analyses, systematic reviews, or RCTs with a high risk of bias

 2++

High quality case control or cohort studies with a very low risk of confounding or bias and a high probability that the relationship is causal

 2+

Well conducted case control or cohort studies with a low risk of confounding or bias and a moderate probability that the relationship is causal

 2-

Case control or cohort studies with a high risk of confounding or bias and a significant risk

 3

Non-analytic studies, e.g. case reports, case series

 4

Expert opinion

 ✔ Recommended best practice based on the clinical experience of the guideline development group [22]